Bhatt Padmanabh P., Senior VP of IP and CSO at Supernus Pharmaceuticals ($SUPN), made one open market sale of company shares in the last year, totaling $31,552. His most recent sale occurred on December 18, 2025. This ranks him 10,772nd out of 11,678 insiders by sales value, well below the average of $8.6 million across 6.4 transactions. He reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 18000 | $32.20 | 62,044.0000 | 56,552,741 | 40.87% | 0.03% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 34114 | $50.18 | 32,930.0000 | 56,552,741 | 50.88% | 0.06% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 15886 | $50.49 | 17,044.0000 | 56,552,741 | 48.24% | 0.03% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 22750 | $39.40 | 39,794.0000 | 56,552,741 | 133.48% | 0.04% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 12250 | $36.75 | 52,044.0000 | 56,552,741 | 30.78% | 0.02% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 15000 | $38.60 | 67,044.0000 | 56,552,741 | 28.82% | 0.03% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 12250 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.02% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 15000 | $0.00 | 5,000.0000 | 56,552,741 | 75.00% | 0.03% |
| March 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 7250 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.01% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 27710 | $49.95 | 39,334.0000 | 56,552,741 | 41.33% | 0.05% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 22290 | $50.73 | 17,044.0000 | 56,552,741 | 56.67% | 0.04% |
| March 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 7250 | $39.40 | 24,294.0000 | 56,552,741 | 42.54% | 0.01% |
| March 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 6838 | $49.55 | 17,456.0000 | 56,552,741 | 28.15% | 0.01% |
| March 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 412 | $50.48 | 17,044.0000 | 56,552,741 | 2.36% | 0.00% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 22750 | $0.00 | 12,250.0000 | 56,552,741 | 65.00% | 0.04% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 4250 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.01% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 18000 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.03% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 5000 | $0.00 | 15,000.0000 | 56,552,741 | 25.00% | 0.01% |
| March 17, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 22750 | $0.00 | 7,250.0000 | 56,552,741 | 75.83% | 0.04% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 22750 | $36.75 | 39,794.0000 | 56,552,741 | 133.48% | 0.04% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 4250 | $29.61 | 44,044.0000 | 56,552,741 | 10.68% | 0.01% |
| March 16, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 5000 | $27.94 | 67,044.0000 | 56,552,741 | 8.06% | 0.01% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1250 | $0.00 | 1,250.0000 | 56,552,741 | 50.00% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 650 | $50.69 | 17,044.0000 | 56,552,741 | 3.67% | 0.00% |
| Feb. 25, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1250 | $0.00 | 17,694.0000 | 56,552,741 | 7.60% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1250 | $0.00 | 2,500.0000 | 56,552,741 | 33.33% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 750 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 646 | $50.86 | 16,444.0000 | 56,552,741 | 3.78% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1250 | $0.00 | 17,090.0000 | 56,552,741 | 7.89% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 354 | $50.86 | 15,840.0000 | 56,552,741 | 2.19% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 750 | $0.00 | 16,194.0000 | 56,552,741 | 4.86% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 581 | $51.35 | 15,444.0000 | 56,552,741 | 3.63% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1125 | $0.00 | 16,025.0000 | 56,552,741 | 7.55% | 0.00% |
| Feb. 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1125 | $0.00 | 3,375.0000 | 56,552,741 | 25.00% | 0.00% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Restricted Stock Unit | 3000 | $0.00 | 3,000.0000 | 56,552,741 | 9999.99% | 0.01% |
| Feb. 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Employee Stock Option (Right to Buy) | 13500 | $0.00 | 13,500.0000 | 56,552,741 | 9999.99% | 0.02% |
| Dec. 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 710 | $44.44 | 14,508.0000 | 56,552,741 | 4.67% | 0.00% |
| Dec. 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 1500 | $0.00 | 15,218.0000 | 56,552,741 | 10.93% | 0.00% |
| Dec. 18, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Unit | 1500 | $0.00 | 0.0000 | 56,552,741 | 100.00% | 0.00% |
| Nov. 13, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Unit | 1500 | $0.00 | 1,500.0000 | 56,552,741 | 9999.99% | 0.00% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 1250 | $0.00 | 14,299.0000 | 55,958,537 | 9.58% | 0.00% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Unit | 1250 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Aug. 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 581 | $41.46 | 13,718.0000 | 55,958,537 | 4.06% | 0.00% |
| Aug. 7, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Unit | 1250 | $0.00 | 1,250.0000 | 55,958,537 | 9999.99% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 575 | $33.05 | 13,279.0000 | 55,958,537 | 4.15% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 335 | $33.05 | 13,854.0000 | 55,958,537 | 2.36% | 0.00% |
| March 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 575 | $33.05 | 12,704.0000 | 55,958,537 | 4.33% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 1650 | $0.00 | 11,799.0000 | 55,958,537 | 16.26% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 750 | $0.00 | 11,689.0000 | 55,958,537 | 6.86% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 860 | $39.15 | 10,939.0000 | 55,958,537 | 7.29% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1250 | $0.00 | 2,500.0000 | 55,958,537 | 33.33% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,958,537 | 25.00% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 750 | $0.00 | 750.0000 | 55,958,537 | 50.00% | 0.00% |
| Feb. 21, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Units | 1650 | $0.00 | 0.0000 | 55,958,537 | 100.00% | 0.00% |
| Feb. 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1250 | $0.00 | 14,189.0000 | 55,958,537 | 9.66% | 0.00% |
| Feb. 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1250 | $0.00 | 12,939.0000 | 55,958,537 | 10.69% | 0.00% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 55,958,537 | 9999.99% | 0.04% |
| Feb. 19, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Restricted Stock Unit | 4500 | $0.00 | 4,500.0000 | 55,958,537 | 9999.99% | 0.01% |
| Feb. 4, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 9477 | $29.61 | 19,626.0000 | 55,958,537 | 93.38% | 0.02% |
| Feb. 4, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 9477 | $39.70 | 10,149.0000 | 55,958,537 | 48.29% | 0.02% |
| Feb. 4, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 9477 | $0.00 | 4,250.0000 | 55,958,537 | 69.04% | 0.02% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 700 | $0.00 | 13,727.0000 | 55,958,537 | 4.85% | 0.00% |
| Jan. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 2573 | $29.61 | 12,722.0000 | 55,958,537 | 25.35% | 0.00% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Units | 1650 | $0.00 | 1,650.0000 | 55,958,537 | 9999.99% | 0.00% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 700 | $0.00 | 9,477.0000 | 55,958,537 | 6.88% | 0.00% |
| Jan. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 2573 | $0.00 | 10,177.0000 | 55,958,537 | 20.18% | 0.00% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 700 | $39.62 | 10,149.0000 | 55,958,537 | 6.45% | 0.00% |
| Jan. 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 700 | $29.61 | 10,849.0000 | 55,958,537 | 6.90% | 0.00% |
| Jan. 27, 2025 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 2573 | $39.62 | 10,149.0000 | 55,958,537 | 20.22% | 0.00% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 12745 | $36.68 | 9,679.0000 | 56,016,350 | 56.84% | 0.02% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 8750 | $36.68 | 9,679.0000 | 56,016,350 | 47.48% | 0.02% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 8750 | $23.99 | 18,429.0000 | 56,016,350 | 90.40% | 0.02% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 12745 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.02% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 8750 | $0.00 | 0.0000 | 56,016,350 | 100.00% | 0.02% |
| Dec. 3, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 12745 | $25.30 | 22,424.0000 | 56,016,350 | 131.68% | 0.02% |
| Aug. 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 1250 | $0.00 | 10,251.0000 | 55,506,828 | 13.89% | 0.00% |
| Aug. 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Unit | 1250 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.00% |
| Aug. 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 572 | $29.57 | 9,679.0000 | 55,506,828 | 5.58% | 0.00% |
| Aug. 1, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Unit | 1250 | $0.00 | 1,250.0000 | 55,506,828 | 9999.99% | 0.00% |
| March 21, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 14491 | $0.00 | 12,745.0000 | 55,506,828 | 53.21% | 0.03% |
| March 21, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 14491 | $35.31 | 8,570.0000 | 55,506,828 | 62.84% | 0.03% |
| March 21, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 14491 | $25.30 | 23,061.0000 | 55,506,828 | 169.09% | 0.03% |
| March 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 400 | $35.31 | 8,570.0000 | 55,506,828 | 4.46% | 0.00% |
| March 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 400 | $0.00 | 27,236.0000 | 55,506,828 | 1.45% | 0.00% |
| March 20, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 400 | $25.30 | 8,970.0000 | 55,506,828 | 4.67% | 0.00% |
| March 19, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 12364 | $0.00 | 27,636.0000 | 55,506,828 | 30.91% | 0.02% |
| March 19, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 12364 | $25.30 | 20,934.0000 | 55,506,828 | 144.27% | 0.02% |
| March 19, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 12364 | $35.31 | 8,570.0000 | 55,506,828 | 59.06% | 0.02% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 36116 | $12.98 | 44,686.0000 | 55,506,828 | 421.42% | 0.07% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 36116 | $33.48 | 8,570.0000 | 55,506,828 | 80.82% | 0.07% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 36116 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.07% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 26250 | $0.00 | 8,750.0000 | 55,506,828 | 75.00% | 0.05% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 26250 | $23.99 | 34,820.0000 | 55,506,828 | 306.30% | 0.05% |
| March 13, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 26250 | $34.10 | 8,570.0000 | 55,506,828 | 75.39% | 0.05% |
| March 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 3884 | $0.00 | 36,116.0000 | 55,506,828 | 9.71% | 0.01% |
| March 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 3884 | $12.98 | 12,454.0000 | 55,506,828 | 45.32% | 0.01% |
| March 12, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 3884 | $32.99 | 8,570.0000 | 55,506,828 | 31.19% | 0.01% |
| Feb. 26, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 5000 | $0.00 | 0.0000 | 55,506,828 | 100.00% | 0.01% |
| Feb. 26, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 5000 | $30.21 | 8,570.0000 | 55,506,828 | 36.85% | 0.01% |
| Feb. 26, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 5000 | $9.13 | 13,570.0000 | 55,506,828 | 58.34% | 0.01% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1250 | $0.00 | 9,208.0000 | 55,506,828 | 15.71% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 1250 | $0.00 | 3,750.0000 | 55,506,828 | 25.00% | 0.00% |
| Feb. 23, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 638 | $29.06 | 8,570.0000 | 55,506,828 | 6.93% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 750 | $0.00 | 8,330.0000 | 55,506,828 | 9.89% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Restricted Stock Unit | 5000 | $0.00 | 5,000.0000 | 55,506,828 | 9999.99% | 0.01% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Unit | 750 | $0.00 | 1,500.0000 | 55,506,828 | 33.33% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 372 | $27.94 | 7,958.0000 | 55,506,828 | 4.47% | 0.00% |
| Feb. 22, 2024 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 55,506,828 | 9999.99% | 0.04% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Unit | 2500 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 2500 | $0.00 | 8,347.0000 | 61,679,800 | 42.76% | 0.00% |
| Sept. 7, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | F | Common Stock | 1182 | $32.10 | 7,165.0000 | 61,679,800 | 14.16% | 0.00% |
| Aug. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Unit | 2500 | $0.00 | 2,500.0000 | 61,679,800 | 9999.99% | 0.00% |
| May 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 750 | $0.00 | 5,497.0000 | 61,679,800 | 15.80% | 0.00% |
| May 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Performance Share Unit | 750 | $0.00 | 0.0000 | 61,679,800 | 100.00% | 0.00% |
| May 4, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Performance Share Unit | 750 | $0.00 | 750.0000 | 61,679,800 | 9999.99% | 0.00% |
| April 11, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 1500 | $0.00 | 4,747.0000 | 61,679,800 | 46.20% | 0.00% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Employee Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 61,679,800 | 9999.99% | 0.03% |
| Feb. 23, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Restricted Stock Units | 5000 | $0.00 | 5,000.0000 | 61,679,800 | 9999.99% | 0.01% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | D | Restricted Stock Units | 750 | $0.00 | 2,250.0000 | 61,679,800 | 25.00% | 0.00% |
| Feb. 22, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | A | Common Stock | 750 | $0.00 | 3,247.0000 | 61,679,800 | 30.04% | 0.00% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 4826 | $39.92 | 1,644.0000 | 61,679,800 | 74.59% | 0.01% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 4826 | $9.13 | 6,470.0000 | 61,679,800 | 293.55% | 0.01% |
| Jan. 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 4826 | $0.00 | 5,000.0000 | 61,679,800 | 49.11% | 0.01% |
| Jan. 6, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Employee Stock Option (Right to Buy) | 174 | $0.00 | 9,826.0000 | 61,679,800 | 1.74% | 0.00% |
| Jan. 6, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | M | Common Stock | 174 | $9.13 | 1,818.0000 | 61,679,800 | 10.58% | 0.00% |
| Jan. 6, 2023 | SUPERNUS PHARMACEUTICALS, INC. | $SUPN | Bhatt Padmanabh P. | Sr. VP of IP, CSO | S | Common Stock | 174 | $39.90 | 1,644.0000 | 61,679,800 | 9.57% | 0.00% |